Research Collaborations FIMM actively partners with biotech and pharmaceutical companies such as ThinkCyte and Gatesbiomanufacturing, indicating a strong openness to collaborative research projects and joint innovation, which could be a gateway for offering joint development or research support services.
Personalized Medicine Focus As a leader in human genomics and personalized medicine, FIMM presents opportunities to supply cutting-edge genomics technologies, data analytics solutions, or precision medicine platforms to enhance their translational research efforts.
Government and Academic Ties Located in Helsinki with extensive infrastructure, FIMM collaborates closely with academic institutions and government-funded research, opening avenues for public sector research grants, grants management solutions, and advanced laboratory equipment sales.
Technology Utilization Utilizing tools like Drupal, jQuery, and Google Analytics shows a modern digital presence, suggesting potential for digital marketing services, data management solutions, or cloud-based research infrastructure enhancements to support FIMM's innovative environment.
Growth and Funding Potential With revenues between $1M and $10M and active partnerships, FIMM may be receptive to expansion capital, grant facilitation, or research infrastructure investments, creating opportunities for financial and consulting services to support their scaling initiatives.
$1B$10B
$10M$25M
$50M$100M
$100M$250MInstitute for Molecular Medicine Finland (FIMM) uses 7 technology products and services including Drupal, Modernizr, jQuery, and more. Explore Institute for Molecular Medicine Finland (FIMM)'s tech stack below.
| Institute for Molecular Medicine Finland (FIMM) Email Formats | Percentage |
| First.Last@fimm.fi | 50% |
| First.Last@fimm.fi | 50% |
Research ServicesSouthwest Finland, Finland201-500 Employees
Institute for Molecular Medicine Finland (FIMM) is an international research institute in Helsinki focusing on human genomics and personalized medicine. FIMM integrates molecular medicine research, technology center and biobanking infrastructures “under one roof” and thereby promotes translational research and adoption of personalized medicine in health care.
Company Overview
Funding & FinancialsInstitute for Molecular Medicine Finland (FIMM)'s revenue is estimated to be in the range of $1M$10M
Funding & FinancialsInstitute for Molecular Medicine Finland (FIMM)'s revenue is estimated to be in the range of $1M$10M
1-888-653-2347 
support@leadiq.com